Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04919512 |
|---|---|
| Brief Title: | A Study of TAR-200 in Combination With Cetrelimab and Cetrelimab Alone in Participants With Muscle-Invasive Urothelial Carcinoma of the Bladder (SunRISe-4) |
| First Submitted : | June 8, 2021 |
| First Submitted that Met QC Criteria : | June 8, 2021 |
| First Posted : | June 9, 2021 |
| Last Update Submitted that Met QC Criteria : | March 23, 2023 |
| Last Update Posted : | March 24, 2023 |